Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Avidity Biosciences, Inc.
San Diego, California
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated April 3, 2020 (except for the “Reverse Stock Split” paragraph of Note 11, as to which the date is June 8, 2020), relating to the financial statements of Avidity Biosciences, Inc. (the “Company”), which is contained in that Prospectus.
We also consent to the reference to us under the heading “Experts” in the Prospectus.
/s/ BDO USA, LLP
San Diego, California
June 11, 2020
